<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cancer &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/category/news/science-news/cancer-science-news/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 30 May 2026 23:32:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Cancer &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Study Reveals Cancer Diagnostic Delays Linked to Population-Based Screening Using Cell-Free DNA Multicancer Early Detection Test</title>
		<link>https://bioengineer.org/study-reveals-cancer-diagnostic-delays-linked-to-population-based-screening-using-cell-free-dna-multicancer-early-detection-test/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 30 May 2026 23:32:05 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-reveals-cancer-diagnostic-delays-linked-to-population-based-screening-using-cell-free-dna-multicancer-early-detection-test/</guid>

					<description><![CDATA[A groundbreaking investigation into the ramifications of population-based multicancer early detection (MCED) screening trials has shed new light on the nuanced interplay between enhanced diagnostic technologies and healthcare system demands. This study meticulously analyzed regional participation in a large-scale MCED screening trial, uncovering a subtle yet clinically relevant increase in diagnostic delays for patients evaluated [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355854</post-id>	</item>
		<item>
		<title>Peptide-Directed, Hypoxia-Sensitive AAV System Enables Tumor-Specific Delivery of Chemokines and PNAi in Non-Small Cell Lung Cancer</title>
		<link>https://bioengineer.org/peptide-directed-hypoxia-sensitive-aav-system-enables-tumor-specific-delivery-of-chemokines-and-pnai-in-non-small-cell-lung-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 30 May 2026 14:15:03 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/peptide-directed-hypoxia-sensitive-aav-system-enables-tumor-specific-delivery-of-chemokines-and-pnai-in-non-small-cell-lung-cancer/</guid>

					<description><![CDATA[In a bold leap toward precision oncology, researchers have proposed an innovative adeno-associated virus (AAV) vector system engineered to selectively target non-small cell lung cancer (NSCLC) cells within their uniquely hostile microenvironment. This advanced platform harnesses a multifaceted approach intertwining capsid retargeting, hypoxia-responsive transcriptional control, and RNA interference, all compressed into a single AAV9 vector. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355805</post-id>	</item>
		<item>
		<title>Tile-Based Radiation Therapy Reduces Recurrence Risk in Brain Metastases, ASCO Study Finds</title>
		<link>https://bioengineer.org/tile-based-radiation-therapy-reduces-recurrence-risk-in-brain-metastases-asco-study-finds/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 30 May 2026 12:25:03 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/tile-based-radiation-therapy-reduces-recurrence-risk-in-brain-metastases-asco-study-finds/</guid>

					<description><![CDATA[A groundbreaking advancement in the treatment of brain metastases has emerged from a recent multicenter Phase 3 clinical trial led by The University of Texas MD Anderson Cancer Center. This innovative approach involves implanting cesium-131-loaded collagen tiles directly into the surgical cavity during brain tumor resection. The practice has demonstrated a significant reduction in tumor [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355797</post-id>	</item>
		<item>
		<title>Gene Testing Safely Spares Many Breast Cancer Patients from Chemotherapy</title>
		<link>https://bioengineer.org/gene-testing-safely-spares-many-breast-cancer-patients-from-chemotherapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 29 May 2026 23:54:04 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/gene-testing-safely-spares-many-breast-cancer-patients-from-chemotherapy/</guid>

					<description><![CDATA[A transformative clinical trial led by University College London (UCL) has unveiled compelling evidence that numerous individuals diagnosed with hormone-sensitive breast cancer can safely circumvent chemotherapy by utilizing an advanced genomic testing approach. This finding heralds a significant shift in oncological treatment paradigms, potentially sparing thousands from the debilitating side effects associated with chemotherapy without [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355743</post-id>	</item>
		<item>
		<title>Study Finds Lung Biopsy Cryoprobe Significantly Improves Diagnostic Accuracy Compared to Standard Forceps</title>
		<link>https://bioengineer.org/study-finds-lung-biopsy-cryoprobe-significantly-improves-diagnostic-accuracy-compared-to-standard-forceps/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 29 May 2026 23:48:03 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-finds-lung-biopsy-cryoprobe-significantly-improves-diagnostic-accuracy-compared-to-standard-forceps/</guid>

					<description><![CDATA[A groundbreaking clinical trial has reshaped the landscape of interventional pulmonology by demonstrating a remarkable improvement in diagnostic accuracy when employing cryobiopsy compared to traditional forceps in transbronchial lung biopsies. This advancement holds significant implications for patients afflicted with pulmonary nodules, masses, recent lung transplants, and diffuse parenchymal lung disease, promising not only enhanced diagnostic [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355739</post-id>	</item>
		<item>
		<title>Immunotherapy Addition Demonstrates Sustained Survival Benefits in Long-Term Follow-Up of NRG Oncology Trial for Advanced or Recurrent Endometrial Cancer</title>
		<link>https://bioengineer.org/immunotherapy-addition-demonstrates-sustained-survival-benefits-in-long-term-follow-up-of-nrg-oncology-trial-for-advanced-or-recurrent-endometrial-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 29 May 2026 23:42:04 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/immunotherapy-addition-demonstrates-sustained-survival-benefits-in-long-term-follow-up-of-nrg-oncology-trial-for-advanced-or-recurrent-endometrial-cancer/</guid>

					<description><![CDATA[In a groundbreaking advancement for the treatment of advanced and recurrent endometrial cancer, recent prolonged follow-up results from the NRG Oncology GY018 phase 3 trial have reinforced the survival benefits of incorporating pembrolizumab, an immunotherapy agent, alongside standard chemotherapy. Initially reported immature overall survival data had suggested a promising improvement, but with extended monitoring, these [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355727</post-id>	</item>
		<item>
		<title>Exploring the Link Between Obstructive Sleep Apnea and Lung Cancer: Epidemiology and Underlying Mechanisms</title>
		<link>https://bioengineer.org/exploring-the-link-between-obstructive-sleep-apnea-and-lung-cancer-epidemiology-and-underlying-mechanisms/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 29 May 2026 18:11:03 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exploring-the-link-between-obstructive-sleep-apnea-and-lung-cancer-epidemiology-and-underlying-mechanisms/</guid>

					<description><![CDATA[It looks like your text got cut off at the end. Here is a summary so far, and if you want, I can help complete or expand the review: Summary: Association Between Obstructive Sleep Apnea (OSA) and Lung Cancer Background: OSA is characterized by repeated episodes of partial or complete upper airway obstruction during sleep, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355619</post-id>	</item>
		<item>
		<title>Healthy Lifestyle Shields Childhood Cancer Survivors, Study Finds</title>
		<link>https://bioengineer.org/healthy-lifestyle-shields-childhood-cancer-survivors-study-finds/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 29 May 2026 14:29:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/healthy-lifestyle-shields-childhood-cancer-survivors-study-finds/</guid>

					<description><![CDATA[A recent breakthrough in pediatric oncology research sheds new light on the pivotal role of lifestyle choices in mitigating the long-term health risks faced by childhood cancer survivors. For decades, the focus has predominantly been on the aggressive treatments—such as chemotherapy and radiation—that save young lives but leave survivors vulnerable to chronic health issues later. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355543</post-id>	</item>
		<item>
		<title>Targeted Therapy Shows Superior Results Over Chemotherapy in Treating Difficult Lung Cancer, ASCO Reports</title>
		<link>https://bioengineer.org/targeted-therapy-shows-superior-results-over-chemotherapy-in-treating-difficult-lung-cancer-asco-reports/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 29 May 2026 12:46:04 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/targeted-therapy-shows-superior-results-over-chemotherapy-in-treating-difficult-lung-cancer-asco-reports/</guid>

					<description><![CDATA[In a breakthrough that could redefine treatment standards for a rare subset of lung cancer patients, researchers from The University of Texas MD Anderson Cancer Center have unveiled compelling evidence that sunvozertinib, an innovative targeted therapy, significantly outperforms conventional chemotherapy in managing advanced non-small cell lung cancer (NSCLC) characterized by EGFR exon 20 insertion mutations. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355529</post-id>	</item>
		<item>
		<title>Unraveling Spontaneous Hemorrhage: Breakthroughs Transform Treatment</title>
		<link>https://bioengineer.org/unraveling-spontaneous-hemorrhage-breakthroughs-transform-treatment/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 23:21:07 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/unraveling-spontaneous-hemorrhage-breakthroughs-transform-treatment/</guid>

					<description><![CDATA[The landscape of spontaneous intracerebral hemorrhage (ICH) treatment is undergoing a seismic transformation driven by rapid technological advances, innovative biological strategies, and the integration of precision medicine principles. This revolution is carving new pathways toward reducing the devastating impact of cerebral hemorrhage, which remains a major cause of morbidity and mortality worldwide. Pioneering efforts are [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355424</post-id>	</item>
		<item>
		<title>How Obesity Affects the Spread of Breast Cancer</title>
		<link>https://bioengineer.org/how-obesity-affects-the-spread-of-breast-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 22:08:06 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/how-obesity-affects-the-spread-of-breast-cancer/</guid>

					<description><![CDATA[In a groundbreaking study conducted by researchers at the University of Oklahoma, compelling evidence has emerged linking obesity to distinct molecular and cellular changes that influence the progression of early-stage breast cancer to invasive disease. Published in The American Journal of Pathology, this research provides critical insights into the biological mechanisms by which obesity exacerbates [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355417</post-id>	</item>
		<item>
		<title>New Survey Reveals Majority of Men Associate Meat Consumption with Masculinity</title>
		<link>https://bioengineer.org/new-survey-reveals-majority-of-men-associate-meat-consumption-with-masculinity/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 22:00:54 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-survey-reveals-majority-of-men-associate-meat-consumption-with-masculinity/</guid>

					<description><![CDATA[As June marks Men’s Health Month, a revealing new survey conducted by the Physicians Committee for Responsible Medicine in collaboration with Morning Consult unveils striking perceptions held by men across the United States regarding diet and masculinity. The poll, carried out from May 12 to 14, 2026, involving 1,020 male participants, highlights a predominant association [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355401</post-id>	</item>
		<item>
		<title>Ohio State Researchers Spotlight Cancer Drug Donation Program, Advances in Lung and Breast Cancer Treatment, Lynch Syndrome Screening, and Clinical Trial Access at ASCO 2026</title>
		<link>https://bioengineer.org/ohio-state-researchers-spotlight-cancer-drug-donation-program-advances-in-lung-and-breast-cancer-treatment-lynch-syndrome-screening-and-clinical-trial-access-at-asco-2026/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 20:25:05 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ohio-state-researchers-spotlight-cancer-drug-donation-program-advances-in-lung-and-breast-cancer-treatment-lynch-syndrome-screening-and-clinical-trial-access-at-asco-2026/</guid>

					<description><![CDATA[Researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) are set to unveil a series of groundbreaking studies at the 2026 American Society of Clinical Oncology (ASCO) annual meeting. These investigations span a broad spectrum of cancer research, covering novel [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355373</post-id>	</item>
		<item>
		<title>AI-Driven Atlas Uncovers Novel Prognostic and Therapeutic Insights into Tertiary Lymphoid Structures in Cancer</title>
		<link>https://bioengineer.org/ai-driven-atlas-uncovers-novel-prognostic-and-therapeutic-insights-into-tertiary-lymphoid-structures-in-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 20:13:05 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ai-driven-atlas-uncovers-novel-prognostic-and-therapeutic-insights-into-tertiary-lymphoid-structures-in-cancer/</guid>

					<description><![CDATA[A groundbreaking study from The University of Texas MD Anderson Cancer Center has unveiled a comprehensive spatial atlas of tertiary lymphoid structures (TLSs) across multiple cancer types, offering an unprecedented insight into these specialized immune microenvironments and their complex roles in cancer prognosis and therapeutic response. This innovative work, recently published in Science, leverages advanced [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355346</post-id>	</item>
		<item>
		<title>Keck Foundation Awards Funding to Three Groundbreaking Early-Career Projects at Salk</title>
		<link>https://bioengineer.org/keck-foundation-awards-funding-to-three-groundbreaking-early-career-projects-at-salk/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 20:07:04 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/keck-foundation-awards-funding-to-three-groundbreaking-early-career-projects-at-salk/</guid>

					<description><![CDATA[In an era marked by increasing uncertainty in federal research funding, the W. M. Keck Foundation has launched a pivotal Bridge Funding Initiative aimed at bolstering early-career scientists navigating this fraught landscape. This endeavor has recently recognized the groundbreaking efforts of three distinguished faculty members at the Salk Institute—Drs. Sung Han, Daniel Hollern, and Graham [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355330</post-id>	</item>
		<item>
		<title>CPT1B K321 Crotonylation Drives Heart Dysfunction in Shock</title>
		<link>https://bioengineer.org/cpt1b-k321-crotonylation-drives-heart-dysfunction-in-shock/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 18:23:03 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cpt1b-k321-crotonylation-drives-heart-dysfunction-in-shock/</guid>

					<description><![CDATA[In a groundbreaking study published in Experimental &#038; Molecular Medicine on May 28, 2026, researchers have unveiled a pivotal molecular mechanism contributing to cardiac dysfunction during endotoxic shock, a life-threatening condition often resulting from sepsis. The study, led by Yang N., Yang J., Xu YF., and colleagues, reveals the crucial role of crotonylation at lysine [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355281</post-id>	</item>
		<item>
		<title>New Study Maps Brain Transposable Element RNA Dynamics Across Lifespan and Neurodegenerative Diseases</title>
		<link>https://bioengineer.org/new-study-maps-brain-transposable-element-rna-dynamics-across-lifespan-and-neurodegenerative-diseases/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 18:16:56 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-study-maps-brain-transposable-element-rna-dynamics-across-lifespan-and-neurodegenerative-diseases/</guid>

					<description><![CDATA[In recent years, transposable elements (TEs), often referred to as transposons, have emerged from the shadows of genomic research to take center stage as pivotal players in human biology. These DNA sequences possess the remarkable ability to move or replicate within the genome, and astonishingly, they constitute approximately 40 to 50 percent of the human [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355273</post-id>	</item>
		<item>
		<title>Common Anemia Drug Reveals Promising New Role in Cancer Therapy</title>
		<link>https://bioengineer.org/common-anemia-drug-reveals-promising-new-role-in-cancer-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 16:34:53 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/common-anemia-drug-reveals-promising-new-role-in-cancer-therapy/</guid>

					<description><![CDATA[A groundbreaking study from the University of Oulu and the University of Eastern Finland has unveiled surprising new insights into the function of a class of drugs known as hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs). Originally approved and widely used to treat anemia in patients with chronic kidney disease, these medications have shown unexpected effects [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355260</post-id>	</item>
		<item>
		<title>OHSU Study Reveals Persistent Suicide Risk Among Veterans Battling Cancer</title>
		<link>https://bioengineer.org/ohsu-study-reveals-persistent-suicide-risk-among-veterans-battling-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 16:29:01 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ohsu-study-reveals-persistent-suicide-risk-among-veterans-battling-cancer/</guid>

					<description><![CDATA[A groundbreaking and comprehensive study conducted by Oregon Health &#038; Science University in collaboration with the Veterans Health Administration reveals an alarming and persistent elevation in suicidal behaviors among veterans diagnosed with cancer. This extensive longitudinal research, spanning nearly a decade and analyzing data from over 292,000 veterans, uncovers a critical and often underappreciated aspect [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355239</post-id>	</item>
		<item>
		<title>Scientists Discover New Target to Halt Aggressive Prostate Cancer Progression</title>
		<link>https://bioengineer.org/scientists-discover-new-target-to-halt-aggressive-prostate-cancer-progression/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 28 May 2026 14:50:04 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<guid isPermaLink="false">https://bioengineer.org/scientists-discover-new-target-to-halt-aggressive-prostate-cancer-progression/</guid>

					<description><![CDATA[In a groundbreaking study poised to significantly advance the fight against aggressive prostate cancer, researchers at Columbia University Irving Medical Center have identified the gene Sirtuin 1 (Sirt1) as a crucial driver in the development of neuroendocrine prostate cancer (NEPC). NEPC represents a particularly lethal form of prostate cancer that often emerges following resistance to [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">355196</post-id>	</item>
	</channel>
</rss>
